Validation of a pediatric population pharmacokinetic model for vancomycin.
about
Development of a pharmacokinetic-guided dose individualization strategy for hydroxyurea treatment in children with sickle cell anaemia.Impact of Initial Vancomycin Trough Concentration on Clinical and Microbiological Outcomes of Methicillin-Resistant Staphylococcus aureus Bacteremia in ChildrenTherapeutic drug monitoring in the era of precision medicine: opportunities!The Relationship Between Vancomycin Trough Concentrations and AUC/MIC Ratios in Pediatric Patients: A Qualitative Systematic Review.Use of Individual Pharmacokinetics to Improve Time to Therapeutic Vancomycin Trough in Pediatric Oncology Patients.Vancomycin therapeutic drug monitoring and population pharmacokinetic models in special patient subpopulations
P2860
Validation of a pediatric population pharmacokinetic model for vancomycin.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Validation of a pediatric population pharmacokinetic model for vancomycin.
@ast
Validation of a pediatric population pharmacokinetic model for vancomycin.
@en
type
label
Validation of a pediatric population pharmacokinetic model for vancomycin.
@ast
Validation of a pediatric population pharmacokinetic model for vancomycin.
@en
prefLabel
Validation of a pediatric population pharmacokinetic model for vancomycin.
@ast
Validation of a pediatric population pharmacokinetic model for vancomycin.
@en
P2093
P2860
P1476
Validation of a pediatric population pharmacokinetic model for vancomycin
@en
P2093
Andrea Hahn
Robert W Frenck
Yuanshu Zou
P2860
P304
P356
10.1097/FTD.0000000000000153
P50
P577
2015-06-01T00:00:00Z